Telesis Bio Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q2 2020 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Telesis Bio Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q2 2020 to Q3 2024.
  • Telesis Bio Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $566K, a 51% decline year-over-year.
  • Telesis Bio Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $2.82M, a 39.3% decline year-over-year.
  • Telesis Bio Inc. annual Share-based Payment Arrangement, Expense for 2023 was $3.96M, a 6.33% increase from 2022.
  • Telesis Bio Inc. annual Share-based Payment Arrangement, Expense for 2022 was $3.73M, a 243% increase from 2021.
  • Telesis Bio Inc. annual Share-based Payment Arrangement, Expense for 2021 was $1.09M, a 2426% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $2.82M $566K -$590K -51% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $3.41M $869K -$166K -16% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $3.57M $766K -$390K -33.7% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-10
Q4 2023 $3.96M $616K -$678K -52.4% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-29
Q3 2023 $4.64M $1.16M +$241K +26.3% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 $4.4M $1.04M -$83K -7.42% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $4.48M $1.16M +$756K +189% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-10
Q4 2022 $3.73M $1.29M +$808K +166% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-29
Q3 2022 $2.92M $915K +$515K +129% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 $2.4M $1.12M +$1.02M +1018% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-11
Q1 2022 $1.39M $400K +$300K +300% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-12
Q4 2021 $1.09M $486K Oct 1, 2021 Dec 31, 2021 10-K 2023-03-22
Q3 2021 $400K +$300K +300% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 $100K +$90K +900% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-10
Q1 2021 $100K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-11
Q3 2020 $100K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 $10K Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.